Target intelligence / Profile preview

T cell receptor alpha variable 24 (TRAV24)

Target
TRAV24
Molecular classification
Receptor, Immunoglobulin superfamily, Variable region gene segment of T cell receptor
01

Overview

T cell receptor alpha variable 24 (TRAV24) is a specific variable gene segment encoding part of the variable region of the alpha chain in the T cell receptor (TCR) complex[1][3][9]. This region contributes to the antigen recognition capacity of TCRs expressed on T lymphocytes, enabling the adaptive immune system to detect peptides presented by major histocompatibility complex (MHC) molecules[1][2][4]. TRAV24, like other TCR variable gene segments, provides structural diversity to the antigen-binding site (mainly through the complementarity-determining regions, especially CDR1 and CDR3), shaping T cell specificity to foreign pathogens and altered self[2][8][9]. While TCR variable segments are not themselves direct drug targets, they are crucial as markers and potential engineering sites in T cell-based immunotherapies or diagnostic tools analyzing TCR repertoire diversity and clonal expansions[4][9].

Other names
TCRAV18S1TCRAV24S1TRAV24
02

Mechanism of action

Drugs/biologics targeting T cell receptors generally modulate antigen recognition and T cell activation via the specific variable region. No approved small molecules or direct drugs for TRAV24 specifically[2][4].

03

Biological functions

Antigen recognitionImmune responseSignal transduction
04

Disease associations

InfectionInflammationCancer (immunotherapy context)
05

Safety considerations

On-target autoimmunity (general risk for TCR/CD3 targeting therapies)Cytokine release syndrome (class effect for T cell activating agents)
06

Biomarkers

TCR repertoire analysis (for immune monitoring, e.g., in cancer or infection)[8][9]

Beyond the preview

Go deeper on T cell receptor alpha variable 24 (TRAV24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor alpha variable 24 (TRAV24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call